The long non-coding RNA ANRIL is the best replicated genetic risk locus of coronary artery disease (CAD) and periodontitis (PD), and is independently associated with a variety of other immune-mediated and metabolic disorders and several forms of cancer. Recent studies showed a correlation of decreased concentrations of proximal ANRIL transcripts with homozygous carriership of the CAD and PD main risk alleles. To elucidate the relation of these transcripts to disease manifestation, we constructed a short hairpin RNA in a stable inducible knock-down system of T-Rex 293 HEK cell lines, specifically targeting the proximal transcripts EU741058 and DQ485454. By genome-wide expression profiling using Affymetrix HG1.0 ST Arrays, we identified the transcription of ADIPOR1, VAMP3 and C11ORF10 to be correlated with decreased ANRIL expression in a time-dependent manner. We validated these findings on a transcriptional and translational level in different cell types. Exploration of the identified genes for the presence of disease associated variants, using Affymetrix 500K genotyping and Illumina custom genotyping arrays, highlighted a region upstream of VAMP3 within CAMTA1 to be associated with increased risk of CAD [rs10864294 P 5 0.015, odds ratio (OR) 5 1.30, 95% confidence interval (CI) 5 1.1 -1.6, 1471 cases, 2737 controls] and aggressive PD (AgP; P 5 0.008, OR 5 1.31, 95% CI 5 1.1 -1.6, 864 cases, 3664 controls). In silico replication in a meta-analysis of 14 genome-wide association studies of CAD of the CARDIoGRAM Consortium identified rs2301462, located on the same haplotype block, as associated with P 5 0.001 upon adjustment for sex and age. Our results give evidence that specific isoforms of ANRIL regulate key genes of glucose and fatty acid metabolism.
INTRODUCTION
The long non-coding antisense RNA (lncRNA) ANRIL (CDKN2BAS) is the best replicated genetic risk factor for coronary artery disease (CAD) (1 -6) and periodontitis (PD) (7 -10) to date. Additionally, ANRIL is independently associated on a genome-wide level with a variety of other diseases such as type 2 diabetes, endometriosis, intracranial aneurysma, † 4516-4527 doi:10.1093/hmg/ddt299 Advance Access published on June 27, 2013 megakarypopoiesis (3, 9, (11) (12) (13) (14) (15) (16) (17) , as well as with several forms of cancer (18 -21) . Additional association with Alzheimer's disease was reported (22) . ANRIL is transcribed and spliced in a complex pattern and a large variety of transcripts exist (23) (24) (25) . The main transcripts are two short forms, both terminating with polyadenylated exon 13, EU741058 (exons 1, 5, 6, 7, 13) and DQ485454 (exons 1 -13) , and the long form NR_003529, which lacks exon 13 and terminates with polyadenylated exon 20 (exons [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . This chromosomal region carries the highest number of disease-associated variants of the human genome and is dense for predicted enhancers (26, 27) , indicating a complex regulation. At the chromosomal position of ANRIL (chr.9p21.3) also reside the tumor-suppressor genes cyclindependent kinase 2A (CDKN2A) and 2B (CDKN2B), which have a well-described role in cell proliferation and apoptosis, and recently, a cis-acting silencing mechanism, mediated by specific ANRIL transcripts, was described to negatively regulate CDKN2A/B expression via chromatin remodeling (28) . Association of the genes CDKN2A/B with cancerogenesis is well established but the causal link between CDKN2A/B and CAD is missing (29) . Moreover, a growing number of alternatively spliced ANRIL isoforms were reported for different cell types (23, 24, (30) (31) (32) , with hitherto unknown biological functions. ANRIL is regulated at least by STAT1 signaling (26) , a pathway that mediates response to inflammation upon stimulation of the pro-inflammatory cytokine interferon gamma, and earlier, we showed that bacterial infection up-regulates ANRIL transcription in gingival tissues (8) , supporting a role of ANRIL in the inflammatory response. Additionally, genome-wide association study (GWAS) lead SNPs of CAD were found to be correlated with the severity of atherosclerosis (25) and this correlation was shown to be independent of most traditional risk factors of CAD (33) , indicating a hitherto unknown component of the disease. However, GWAS lead SNPs that were associated with cancer were not in linkage disequilibrium (LD) with the CAD-associated lead SNPs, and are strongly associated with CDKN2A and CDKN2B expression but not with the expression of ANRIL (32). The observations that lead SNPs of different diseases have a different influence on ANRIL and CDKN2A/B expression indicate different contributions of these SNPs to the modulation of transcripts, which are crucial for the pathogenesis of the different conditions. But how the disease-associated variants of this tissue-specific and alternatively spliced lncRNA translate into different diseases such as CAD, PD, cancer and others has remained unknown. A number of CAD-associated variants at this chromosomal locus were predicted to disrupt annotated transcription factor-binding sites (27) . Various studies investigated the association of GWAS lead SNPs of CAD with the expression of ANRIL, CDKN2A and CDKN2B and showed different correlations of the risk haplotype with the expression of these genes in different tissues or cell types, indicating cell type-specific splicing and tissue-specific effects of the risk haplotype (23) (24) (25) 29, 31, 32, 34, 35) . The differences between these studies may be related to the usage of different cell types of tissues, to the analysis of different transcriptional isoforms, which are likely to be differentially regulated, or to the sample size of the studies. Furthermore, the modulation of transcript levels might be specific to particular conditions of regulatory activation that are not easily detected. However, there is some consistency among the studies that the risk haplotype is associated with decreased levels of the short, more complex isoform DQ485454, indicating a role of the 5 ′ exons of ANRIL (23, 29, 31, (34) (35) (36) in the disease etiology of CAD and PD. According to the observations that other lncRNAs were shown to be involved in the trans-regulation of gene expression (37), we hypothesized a trans-regulatory function of the 5 ′ ANRIL transcripts on target genes that are relevant for the disease etiology of CAD and PD. We designed short hairpin RNAs (shRNA) to target polyadenylated exon 13. Thus, we excluded transcripts from the analysis, which carried the distal exons (exons [14] [15] [16] [17] [18] [19] , and constructed a stable tetracycline-inducible knock-down system in the T-Rex 293 (HEK 293) cell line (a derivative of the human embryonic kidney 293 fibroblast cell line; Supplementary Material).
In the current study, we identified three genes, ADIPOR1, VAMP3 and C11ORF10, to be regulated by ANRIL in a time-dependent manner. These genes all have a well-described role in fatty acid and glucose metabolism, as well as in inflammation. Two of these loci carried risk variants, which were shared by PD and CAD or PD and other metabolic and inflammatory traits.
RESULTS
Induced knock-down of ANRIL is negatively correlated with CDKN2A/2B expression and cell proliferation
To identify the time-point of strongest reduction of shRNAmediated knock-down upon tetracycline incubation, we assessed the transcript levels of ANRIL exon 13 in our inducible knock-down cell system at nine different time-points prior to and upon tetracycline induction by quantitative real-time reverse transcription-PCR (qRT-PCR). Exon 13 transcript levels decreased 4 h after induction and reached a minimum after 48 h, with a 2.4-fold reduction compared with the unstimulated controls. Transcript reduction remained stable for at least 96 h upon induction (Supplementary Material, Fig. S1 ). To further test the functionality of our construct, we assessed the previously described negative correlation of the concentration of the proximal transcripts of ANRIL and CDKN2A and -2B expression (28) , and quantified CDKN2A/B transcript levels prior to and 48 and 96 h upon tetracycline induction. CDKN2A and -2B activity lagged ANRIL repression and showed significantly increased concentration 96 h after induction (CDKN2A: 1.5-fold, 96 h upon induction P ¼ 0.014, CDKN2B: 1.3-fold, 96 h upon induction P ¼ 0.0017; Supplementary Material, Fig. S2 ).
As this transcriptional increase of the cell-cycle inhibitors CDKN2A and -2B was expected to reduce cellular proliferation, we assessed T- Fig. 1 ). This statistically significant effect was observed 24 h earlier than the observed significant transcript reduction of CDKN2A/2B (Supplementary Material, Fig. S2 ). Next, we replicated our observation in HeLa cells to exclude false-positive findings due to cell-line-specific artifacts. HeLa cells were transiently transfected with a constitutively expressed shRNA-exon13 knock-down construct, and gene expression was monitored by qRT-PCR 0 and 48 h upon transfection. We observed significantly reduced expression for ADIPOR1 (1.3-fold), VAMP3 (1.5-fold) and C11ORF10 (1.5-fold), compared with untransfected HeLa cells (Fig. 2) .
To rule out that our observations were produced by unspecific effects of the shRNA or by tetracycline treatment, we performed qRT-PCR for these genes in T-Rex 293 cells that were stably transfected with a pENTR TM /H1/TO vector, which expressed a non-specific shRNA upon tetracycline induction. No differences in gene expression were observed with and without tetracycline incubation (Supplementary Material, Fig. S5 ).
To further validate the effects of reduced concentrations of ANRIL exon-13 isoforms on the protein abundance of VAMP3, ADIPOR1 and C11ORF10, we performed western blot analysis using our stably transfected T-REX 293 cell line. Seven days upon tetracycline induction, protein abundance of all three genes was reduced compared with the unstimulated controls (Fig. 3 ).
Genetic analysis of the chromosomal regions of ADIPOR1, VAMP3 and C11ORF10
Within the coding regions of ADIPOR1 and VAMP3, no genomewide SNP association was reported for any disease or trait. However, 3 kilobases (kb) downstream of VAMP3, a GWAS on Crohn's disease (CD) reported genome-wide associations with PER3 (period circadian protein homolog 3) (39); 2 kb upstream of VAMP3, the extremely large chromosomal region of CAMTA1 (calmodulin-binding transcription activator1) is located, spanning .1 megabase and being rich in enhancer elements. A recent study reported suggestive evidence of a large chromosomal region within CAMTA1 to be associated with periodontal pathogen colonization (40) . To search for potential associated disease variants across this chromosomal region, we genotyped the 3 ′ end of CAMTA1 (91 kb) and the chromosomal region across VAMP3, and PER3 (466 kb) with 524 SNPs [mean distance 0.9 + 1.2 kb, minor allele frequency (MAF)
.5%], using the immunochip (Illumina, USA). We genotyped 600 German aggressive periodontitis (AgP) cases, and 1440 German population representative controls. At our pre-assigned significance threshold of association, at least two neighboring SNPs with P , 0.01, we identified no significant SNP associations within the 3 ′ end of CAMTA1, VAMP3, PER3 and PARK7. The region that was described to be associated with periodontal pathogen colonization was not covered by the immunochip, and to test this region for the potential association with AgP, we used Affymetrix 500K Gene Array genotype data of our previous GWAS (41) . Within CAMTA1, we observed several significant SNP associations in our GWAS data, of which the variants rs10864294 and rs17030881 gave the best association signal (Supplementary Material, Fig. S6 ). Both SNPs, which are not in LD (r 2 , 0.8), are located directly upstream of the region that was described to be associated with periodontal pathogen colonization. The sequences, which span rs10864294, are highly conserved in mammals (not existing in other classes) and the sequences, which span rs17030881, are highly conserved from amphibians to mammals. To increase statistical power, we tested the association in our complete AgP case-control sample of 864 German, Austrian and Dutch AgP cases and 3664 geographically matched healthy controls. rs10864294 was associated with P ¼ 0.008 and an odds ratio (OR) ¼ 1.31 [95% confidence interval (CI) 1.1-1.6], and rs17030881 was associated with P ¼ 0.002, OR ¼ 4.36 (95% C.I. 1.5-12.5; Table 2 ). We validated the associations of these SNPs in 1471 North German nonobese CAD cases (BMI , 30) and 2737 geographically matched healthy controls. In the CAD cases, carriership of rs10864294 was associated with P ¼ 0.015, OR ¼ 1.3 (95% C.I. ¼ 1.1-1.6), and carriership of rs17030881 was associated with P ¼ 0.009, OR ¼ 6.09 (95% C.I. ¼ 1.3-28.7, Table 2 ). Finally, we performed an in silico replication using a meta-analysis of 14 genome-wide association studies of CAD comprising 22 233 individuals with CAD and 64 762 controls of European descent (2) . SNP rs10864294 showed poor genotype quality in the overall analysis but was in complete LD (D ′ ¼ 1, Supplementary Material, Table S7 ) with another SNP, rs2301462, upstream of 760 bp. In this meta-analysis, rs2301462 was associated with P ¼ 0.00106 in an additive genetic model upon adjustment for age and sex. C11ORF10 locates 7 kb distal to the FADS 1-3 (fatty acid desaturases 1-3) gene cluster. A haplotype across C11ORF9, C11ORF10, FADS1 and FADS2 was reported to show genomewide significant associations with the metabolic syndrome (42), altered phospholipids concentrations (43), T2D (44) and CD (39), but not with CAD. To test this chromosomal region for association with PD, we analyzed variants within C11ORF9, C11ORF10, FADS1 and FADS2 in our German AgP casecontrol sample, using the immunochip (Table 2) . We observed nominal significant association of this haplotype block with our case-control panel of AgP (Table 2, For the chromosomal region around ADIPOR1 (.200 kb), our 500K GWAS data of AgP showed no SNP association. Likewise, no genome-wide association with any disease has been reported for ADIPOR1.
The observed co-regulation of ADIPOR1, VAMP3 and C11ORF10 by ANRIL suggested the existence of shared conserved nucleotide sequences (CNS) of these genes, which could have the potential to serve as binding sites for shared regulatory proteins. To identify such elements, we analyzed the coding sequence of each gene, including additional 2500 bp up-and downstream of the start and stop codon for shared CNS, using the publicly available software tool mVISTA (45) . Three CNS of at least 200 bp length and with .70% sequence identity were found to be shared with ADIPOR1, VAMP3 and C11ORF10. VAMP3 and C11ORF10 shared four CNS (Fig. 4) . Several identical transcription factor-binding sites were predicted for each of the three CNS that are shared between the three genes (Supplementary Material, Table S4 ).
Overexpression of ANRIL exons 1-5-6-7-13
Our knock-down construct targeted all transcriptional isoforms of ANRIL, which terminated with exon 13, but the full spectrum of alternative isoforms of these transcripts is currently unknown. To study the effects of increased expression of 5 ′ exons on the identified target genes, we over-expressed a transcript, innate to HUVEC cells (24) and gingival epithelial cells, that incorporated the proximal exons 1-5-6-7-13. Upon 48 h of tetracycline induction, we observed a significant upregulation of ANRIL transcripts, which carried exon 13, as well as of C11ORF10. The expression of ADIPOR1 and VAMP3 was not significantly altered (Fig. 5) .
DISCUSSION
lncRNAs were previously shown to be involved in the transregulation of the expression of distant genes (37, 46) . Our data suggest that decreased expression of ANRIL transcripts containing exon 13 is correlated with decreased expression levels of ADIPOR1, VAMP3 and C11ORF10. However, we did not give Reduced protein levels of ADIPOR1, C11ORF10 and VAMP3 upon induced knock-down of the distal isoforms of ANRIL transcripts. Knock-down of ANRIL isoforms terminating with exon 13 led to reduced cellular protein levels of ADIPOR1, C11ORF10 and VAMP3 after 7 days. Whereas ADIPOR1 and C11ORF10 only were detected in the cytoplasm fraction, VAMP3 was also found in the membrane fraction, where protein concentration was also reduced.
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direct evidence for the interaction of ANRIL transcripts with the transcriptional complex of the identified target genes. Because the expression of specific ANRIL transcripts and CDKN2A/2B is co-regulated through usage of the same transcriptional start site (28) , it can be argued that the effects, which were observed in our study, may be mediated through antisense transcription regulation of CDKN2A/2B. However, our data showed a transcriptional response of ADIPOR1, VAMP3 and C11ORF10 24 h earlier compared with the cis-regulated genes CDKN2A/ 2B. Likewise, other studies repeatedly showed that the effects of sequence variants acting in cis were stronger for ANRIL than for CDKN2A/2B expression (25, 29, 31, 32) . A late significant impact on the transcriptional regulation of CDKN2A and -2B upon shRNA induction was also observed for other antisense ANRIL transcripts, which showed increasing effects with longer intervals of antisense expression (24 cell passages compared with 12 cell passages) (28) . This study also gave evidence that ANRIL RNA participates directly in the regulation of chromatin structure. It is possible, although highly speculative, that ANRIL regulation of the identified target genes is mediated by transcription factors instead of the regulation of chromatin structure. These different mechanisms could result in different reaction times to shRNA gene silencing. Further support for a direct role of ANRIL transcripts on distant target genes was obtained by the overexpression experiment of our own study. The vector, which inducibly over-expressed the short ANRIL transcript form EU741058 (exons 1-5-6-7-13), integrated randomly into the genome. Interestingly, we saw an effect only on C11ORF10 transcript levels. The fact that we did not observe an increase of ADIPOR1 and VAMP3 transcript levels could be attributable to unknown position effects, or, that transcripts other than EU741058 were required for specific regulation of these target genes. Generally, the usage of different exons may confer different biological functions to different isoforms, and the increasing number of different and cell-type-specific ANRIL transcripts that are being discovered (23,24,31) indicate such functions also for ANRIL transcript forms. Experiments which overexpress other transcripts will be able to test this hypothesis. ADIPOR1 is a high-affinity receptor for globular adiponectin, a hormone which, e.g., mediates AMPK and PPAR-alpha ligand activities (47) , key regulators of fatty acid oxidation and regulation of glucose levels. A negative correlation of body fat and adiponectin levels is well established (48, 49) . Apart from the function of globular adiponectin to increase fatty acid oxidation, it also strongly increases insulin's ability to stimulate glucose uptake through increased glucose transporter 4 (GLUT4) gene expression and increased GLUT4 recruitment to the plasma membrane (50, 51) . The hormone plays a role in type 2 diabetes and atherosclerosis, where it may also attenuate the inflammatory response associated with, e.g., atherogenesis (52) and PD (53) . In this context, adiponectin is found to act as an anti-inflammatory signal by selectively increasing tissue inhibitors of metalloproteinases (54) . It was further established that adiponectin suppresses phagocytic activity and lipopolysaccharide-induced TNF (tumor necrosis factor) expression (55) . VAMP3 belongs to the VAMP/synaptobrevin family and plays a role in phagocytosis, where VAMP3 mediates delivery of TNF-alpha to the cell surface of the phagocytic cup, resulting in a subsequent release of TNF-alpha (56) . Interestingly, Table S7 ). The P-value of rs2301462 was adjusted for age and sex in this meta-analysis. VAMP3 is also involved in GLUT4-mediated glucose metabolism. Elevated insulin levels induce translocation of GLUT4 to the plasma membrane to aid glucose utilization, which is mediated by VAMP3 (57, 58) . Although the function of C11ORF10 is currently unknown, the genetic region across C11ORF9, C11ORF10 and FADS1-2 is associated with various metabolic traits such as the metabolic syndrome, a cluster of cardiovascular and periodontal risk factors that include obesity, impaired glucose tolerance and type 2 diabetes. C11ORF10 is furthermore independently genome-wideassociated with inflammatory bowel disease (39) .
The effects of homozygous carriership of the CAD mainassociated SNPs on the development of CAD were shown to be independent of traditional cardiovascular risk factors and scores (1) . Interestingly, a recent case-control and prospective study showed an almost complete reduction of the effect of homozygous carriership of the CAD main-associated SNPs on the development of CAD in the context of a diet high in raw vegetable intake but low in fat (59) . Furthermore, interaction of 9p21.3 variants and glycosylated hemoglobin, a marker of hyperglycemia, on coronary heart disease in individuals with type 2 diabetes was reported (60) . In this study, the genetic effect of 9p21.3 variants on CAD 
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was found to be magnified in the presence of poor glycemic control. However, recent data of the Framingham Heart Study showed no evidence for the association of the CAD risk haplotype (rs1333049) with traditional CAD risk factors such as cholesterol and low-density lipoprotein (LDL) (34) . One potential explanation is that the modulation of the concentration of these metabolites may be specific to particular conditions that are not easily detected in cross-sectional surveys. In this context, it was also discussed that there is a complex regulatory space at the chr.9p21.3 locus and that disease-associated alleles may have conditionspecific effects (26) . Interestingly, carriership of the risk C allele of the GWAS lead SNP rs1333049 is comparatively common in both European and Asian populations (MAF HapMap-CEU ¼ 49.2%, HapMap-HCB ¼ 47.8%, HapMap-JPT ¼ 51.1%), where homozygosity even seems to be balanced for both alleles (HapMap-CEU: CC ¼ 22.0%, TT ¼ 23.7%; HapMap-JPT: CC ¼ 26.7%, TT ¼ 24.4%), whereas in Sub-Sahara populations the C-allele is comparatively rare (HapMap-YRI 17.5%, CC ¼ 1.7%). Interestingly, a similar enrichment of the risk-associated alleles of the haplotype block spanning the genes C11ORF9-10 and FADS1-2 was observed for European (MAF HapMap-CEU ¼ 34%) and Asian populations (MAF HapMap-HCB ¼ 34%, HapMap-JPT ¼ 31%) compared with the Sub-Saharan population (MAF HapMap-YRI ¼ 11%), where no homozygous carriers of the rare alleles were observed. The correlation of low frequencies of these risk haplotype blocks in Sub-Sahara populations together with the role of ANRIL transcripts on ADIPOR1, VAMP3 and C11ORF10 protein levels described in the current study might be interesting in the context of earlier observations that found LDL cholesterol and apolipoprotein B levels in westernized Africans to be significantly lower in black neonates when compared with white neonates (61) .
Interestingly, also strong differences in MAF for rs10864294 upstream of VAMP3, which we showed to be increased in CAD patients and AgP cases, were observed between European and Asian populations, and Sub-Sahara populations (HapMap-CEU ¼ 7.5%, HapMap-JPT ¼ 5.3%, HapMap-YRI ¼ 51.3%). In conclusion, our findings place specific ANRIL transcripts, which are modulated by the main CAD-and PD-associated haplotype, into a regulatory network that integrates glucose and fatty acid metabolism and immune response, and add important pieces to the yet-unassembled puzzle of the molecular role of ANRIL transcripts in the etiology of these diseases. Future identification of the exact transcript forms of ANRIL that mediate the expression of the described target genes and the identification of the putative RNA-binding proteins will help to further understand the molecular function of ANRIL. Other haplotypes are independently associated with increased susceptibility to other diseases such as diabetes and cancer. The systematic elucidation of the full spectrum of transcripts that are modulated by these variants and the characterization of their biological functions will help to identify the regulatory networks that play a role in the etiology of such different diseases such as cancer, T2D, CAD, PD and Alzheimer, which are all connected by this differentially spliced lncRNA.
MATERIALS AND METHODS

Ethics statement
Written informed consent was obtained from all participants and the recruitment and the experimental protocols were approved by the institutional ethics review board and data protection authorities.
Study population
For detailed descriptions of the component studies, see Supplementary Material.
Construction of a stable tetracycline-inducible shRNA knock-down or overexpression system in T-Rex 293 (HEK 293) cell lines For a detailed description on the PCR conditions, primer sequences and protocols, see Supplementary Material. In brief, single-stranded DNA oligonucleotides were designed using the manufacturer's software RNAi Designer (www.invitrogen. com/rnai). Double-stranded oligonucleotides were annealed and cloned into the pENTR TM /H1/TO vector according to the manufacturer's instructions (Invitrogen, USA). To generate a stable cell line, the pENTR TM /H1/TO construct was transfected into T-REX 293 cells using FuGene (transfection reagent, Promega), according to the manufacturer's protocol (Promega, USA). Six hours after transfection, the medium was removed and replaced with fresh growth medium (DMEM+10% FCS, Life Technologies, USA). Cells were incubated over night at 378C. The following day, cells were replaced to a larger sized tissue culture format with fresh growth medium containing Blasticidin (5 mg/ml) and Zeocin (100 mg/ml). The medium was replaced with fresh growth medium containing Blasticidin and Zeocin every 3 days until Blasticidin-and Zeocin-resistant colonies were selected (14 days after transfection). Twelve Blasticidin-and Zeocin TM -resistant colonies were selected and taken into further cultivation. The same selection procedure was done for the overexpression system, where the transcript containing exons 1-5-6-7-13 was cloned in the pcDNA4/ TO vector.
Analysis of cell proliferation
Cell proliferation of T-Rex 293 cells was estimated by counting the number of cells/milliliter over time (cellometer auto T4 counter, Nexcelom Bioscience, USA). In brief, six 10 ml dishes were plated with a liquid culture medium containing T-REX cells (carrying the stably integrated shRNA targeted to exon 13 of ANRIL) with a density of 5.5 × 10 5 cells/ml. To induce the expression of the shRNA, the growth medium was supplemented with 1 mg/ml tetracycline for three plates, whereas the remaining three plates were not supplemented with tetracyclin. Plates/cells were split every third day and cell number/milliliter was determined with the cellometer auto T4 counter for each plate in triplicates. The same procedure was repeated for T-REX cells, which were not stably transfected with shRNA against exon 13.
Transfection of HeLa cells
For transient transfection, HeLa cells were grown in 10 ml culture dishes until 60% confluency. Cells were transfected with the pENTR TM /U6 construct using FuGene (transfection reagent, Promega) according to the manufacturer's protocol (Promega). Six hours after transfection, the medium was removed and replaced with fresh growth medium (DMEM+10% FCS, Life Technologies).
Genome-wide transcriptome profiling
Total RNA was isolated, processed and hybridized to Affymetrix Human Gene 1.0 ST Arrays according to the manufacturer's instructions. Data were normalized using the open-source software RMA (R, Bioconductor, USA). Fold changes were calculated based on the ratios of the medians, and FDRs were estimated using a Westfall -Young permutation as described in the 'Wiley Series in Probability and Mathematical Statistics', Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment by Peter Westfall and Stanley Young (New York, 1993), with 5000 permutations. Transcripts were considered differentially expressed when the FDR was ≤1% and no outlier was identified (62) . Outliers were defined as transcripts with relative expression values that are located within the range of the other experimental group when comparing two experimental groups. Cluster analysis was performed using the TIBCO Spotfire IBD software (Tibco, USA) employing correlation as a distance measure. Five replicates were performed for each of the time-points 0, 48 and 96 h.
Western blot
shRNA expression targeting exon 13 was induced by tetracycline incubation for 7 days. Growth medium was changed every third day. Cells were fractionated in ctyosolic and membrane fraction as follows. Cells grown in 10 ml dishes were washed with cold PBS and 500 ml of cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 10 mM NaF, phosphatase and protease inhibitor). Plates were scraped, placed into a 1.5 ml tube and incubated at 48C for 10 min. Lysate was passed through 26 G needle 15 times using a 1 ml syringe and centrifuged for 10 min with 1000g at 48C. Supernatant was removed and centrifuged an additional time for 45 min with 16 000g at 48C. Next, the
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supernatant was removed as cytosolic fraction, whereas the pellet was washed with buffer A, and resuspended in RIPA buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, phosphatase and protease inhibitor) as membrane fraction. Cytosolic and membrane fractions of tetracycline-stimulated and -unstimulated controls were separated by electrophoresis, and western blotting was performed following standard protocols.
Genotyping and statistical analysis
Genotypes for the chromosomal regions of VAMP3 and C11ORF10 and additionally, 91 kb of the downstream part of CAMTA1 were generated using the custom genotyping array Immunochip (Illumina). The genotypes were automatically called using the GenomeStudio Data analysis software package with the integrated GenCall algorithm (Illumina). All raw genotyping data were combined for clustering and quality control according to the manufacturers instructions. SNPs failed with a call rate ,98% and/or cluster separation score ,0.4 were excluded. The final sample size for the explorative part of the study was 600 AgP cases and 1441 controls. SNPs with an MAF ,5% were filtered and removed prior to the analysis. Genotypes for CAMTA1 and ADIPOR1 were generated with the Affymetrix Gene Chip Human Mapping 500K Array Set. Controls were genotyped with the Affymetrix Gene Chip 5.0. SNPs with a genotype call rate ,90% were excluded. GWAS genotype data were automatically called by the BRMBLL algorithm. Genotyping of rs17030881 and rs10864294 (CAMTA1) was additionally performed using the TaqMan Genotyping System (Applied Biosystems, USA) on an automated platform, employing TECAN Freedom EVO and 96-well and 384-well TEMO liquid-handling robots (TECAN, Switzerland). All markers were tested for deviations from Hardy-Weinberg equilibrium in controls before inclusion into the analyses (P ¼ 0.05).
Genotypes were analyzed using the PLINK v2.049 software (63) . Significance of association with single-locus genotypes was assessed using x2 tests for allelic 2 × 2 contingency tables. We used genotype, dominant, multiplicative and recessive genetic models to assess the genetic effect of the associated alleles. LD measures and haplotypes were calculated with HaploView 4.2 (64) .
Details of the in silico replication in the CARDIoGRAM Consortium have been reported elsewhere (2) .
